S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
The single greatest medical breakthrough of all time? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Greek authorities rescue 91 migrants from river islet on border with Turkey
The single greatest medical breakthrough of all time? (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Wall Street Legend Who Called AMZN Crash Issues New Sell Alert (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
The single greatest medical breakthrough of all time? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Greek authorities rescue 91 migrants from river islet on border with Turkey
The single greatest medical breakthrough of all time? (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Wall Street Legend Who Called AMZN Crash Issues New Sell Alert (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
The single greatest medical breakthrough of all time? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Greek authorities rescue 91 migrants from river islet on border with Turkey
The single greatest medical breakthrough of all time? (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Wall Street Legend Who Called AMZN Crash Issues New Sell Alert (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Saudi Arabia is slashing oil supply. It could mean higher gas prices for US drivers
The single greatest medical breakthrough of all time? (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Greek authorities rescue 91 migrants from river islet on border with Turkey
The single greatest medical breakthrough of all time? (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
US, UK navies say they responded to distress call as Iran's Revolutionary Guard 'harassed' ship
Wall Street Legend Who Called AMZN Crash Issues New Sell Alert (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Saudi Arabia to reduce oil output by 1 million barrels per day, while rest of OPEC+ extends previous cuts through 2024
NASDAQ:PRQR

ProQR Therapeutics (PRQR) News Today

$1.89
+0.04 (+2.16%)
(As of 06/2/2023 ET)
Compare
Today's Range
$1.81
$1.92
50-Day Range
$1.67
$3.59
52-Week Range
$0.68
$3.85
Volume
325,800 shs
Average Volume
377,297 shs
Market Capitalization
$152.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.35
Get ProQR Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRQR and its competitors with MarketBeat's FREE daily newsletter.



PRQR Media Mentions By Week

PRQR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PRQR
News Sentiment

1.09

0.56

Average
Medical
News Sentiment

PRQR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PRQR Articles
This Week

5

2

PRQR Articles
Average Week

SourceHeadline
MarketBeat logoAnalysts Offer Predictions for ProQR Therapeutics' FY2024 Earnings (NASDAQ:PRQR)
americanbankingnews.com - May 30 at 2:00 AM
marketbeat.com logoProQR Therapeutics (NASDAQ:PRQR) to Post FY2024 Earnings of ($0.51) Per Share, Chardan Capital Forecasts
marketbeat.com - May 29 at 2:28 AM
marketbeat.com logoM28 Capital Management LP Grows Stake in ProQR Therapeutics (NASDAQ:PRQR)
marketbeat.com - May 26 at 2:50 PM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) to Post FY2023 Earnings of ($0.47) Per Share, Cantor Fitzgerald Forecasts
americanbankingnews.com - May 24 at 1:38 AM
markets.businessinsider.com logoChardan Capital Remains a Hold on ProQR (PRQR)
markets.businessinsider.com - May 23 at 8:56 PM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) Lifted to "Hold" at StockNews.com
americanbankingnews.com - May 23 at 2:32 AM
marketbeat.com logoBrokers Set Expectations for ProQR Therapeutics' FY2023 Earnings (NASDAQ:PRQR)
marketbeat.com - May 22 at 1:43 AM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) Price Target Cut to $4.50
americanbankingnews.com - May 21 at 2:38 AM
MarketBeat logoAnalysts Set Expectations for ProQR Therapeutics' Q2 2023 Earnings (NASDAQ:PRQR)
americanbankingnews.com - May 21 at 1:30 AM
MarketBeat logoProQR Therapeutics to Post Q4 2023 Earnings of $0.36 Per Share, HC Wainwright Forecasts (NASDAQ:PRQR)
americanbankingnews.com - May 20 at 3:58 AM
marketbeat.com logoQ2 2023 EPS Estimates for ProQR Therapeutics Increased by Analyst (NASDAQ:PRQR)
marketbeat.com - May 19 at 7:33 AM
finance.yahoo.com logoProQR Therapeutics N.V. (NASDAQ:PRQR) Could Be Less Than A Year Away From Profitability
finance.yahoo.com - May 18 at 9:53 AM
msn.com logoHC Wainwright & Co. Reiterates ProQR Therapeutics N.V (PRQR) Buy Recommendation
msn.com - May 17 at 6:57 PM
msn.com logoJMP Securities Reiterates ProQR Therapeutics N.V (PRQR) Market Outperform Recommendation
msn.com - May 17 at 6:57 PM
msn.com logoAnalyst Ratings for ProQR Therapeutics
msn.com - May 17 at 1:57 PM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for ProQR (PRQR)
markets.businessinsider.com - May 17 at 7:39 AM
msn.com logoRecap: ProQR Therapeutics Q1 Earnings
msn.com - May 16 at 4:39 PM
finance.yahoo.com logoProQR Announces First Quarter 2023 Operating and Financial Results
finance.yahoo.com - May 16 at 9:11 AM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) Downgraded by StockNews.com to "Sell"
americanbankingnews.com - May 13 at 6:40 AM
marketbeat.com logoProQR Therapeutics (NASDAQ:PRQR) Lowered to Sell at StockNews.com
marketbeat.com - May 12 at 10:20 PM
marketbeat.com logoProQR Therapeutics (NASDAQ:PRQR) Short Interest Down 20.2% in April
marketbeat.com - May 12 at 11:16 AM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) Receives $4.45 Average Price Target from Analysts
americanbankingnews.com - May 12 at 2:52 AM
finance.yahoo.com logoProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023
finance.yahoo.com - May 9 at 12:36 PM
marketbeat.com logoProQR Therapeutics (NASDAQ:PRQR) Given Consensus Rating of "Moderate Buy" by Analysts
marketbeat.com - May 9 at 1:40 AM
marketbeat.com logoBank of Montreal Can Makes New Investment in ProQR Therapeutics (NASDAQ:PRQR)
marketbeat.com - May 4 at 4:48 AM
finance.yahoo.com logoProQR Announces Upcoming Investor Conferences in April and May
finance.yahoo.com - April 20 at 10:33 AM
finance.yahoo.com logoProQR Announces Annual Meeting of Shareholders to be Held May 17, 2023
finance.yahoo.com - April 18 at 10:26 AM
MarketBeat logoAnalysts Set ProQR Therapeutics (NASDAQ:PRQR) Price Target at $4.45
americanbankingnews.com - April 17 at 2:48 AM
marketbeat.com logoProQR Therapeutics (NASDAQ:PRQR) Given Average Rating of "Moderate Buy" by Analysts
marketbeat.com - April 14 at 2:36 AM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) PT Lowered to $2.25 at Citigroup
americanbankingnews.com - April 10 at 2:36 AM
marketbeat.com logoCitigroup Cuts ProQR Therapeutics (NASDAQ:PRQR) Price Target to $2.25
marketbeat.com - April 7 at 3:22 PM
MarketBeat logoProQR Therapeutics to Post Q1 2023 Earnings of ($0.17) Per Share, HC Wainwright Forecasts (NASDAQ:PRQR)
americanbankingnews.com - April 4 at 1:18 AM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) Lifted to Hold at StockNews.com
americanbankingnews.com - April 3 at 2:00 AM
marketbeat.com logoBrokers Set Expectations for ProQR Therapeutics' Q1 2023 Earnings (NASDAQ:PRQR)
marketbeat.com - April 3 at 1:24 AM
marketbeat.com logoProQR Therapeutics (NASDAQ:PRQR) Upgraded by StockNews.com to Hold
marketbeat.com - March 31 at 10:05 PM
MarketBeat logoAnalysts Offer Predictions for ProQR Therapeutics' Q4 2023 Earnings (NASDAQ:PRQR)
americanbankingnews.com - March 31 at 8:00 AM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) Given New $5.00 Price Target at HC Wainwright
americanbankingnews.com - March 31 at 7:06 AM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) Price Target Increased to $5.00 by Analysts at HC Wainwright
americanbankingnews.com - March 31 at 7:06 AM
marketbeat.com logoEquities Analysts Set Expectations for ProQR Therapeutics' Q4 2023 Earnings (NASDAQ:PRQR)
marketbeat.com - March 31 at 6:51 AM
benzinga.com logoProQR Therapeutics Stock (NASDAQ:PRQR), Earnings Estimates, EPS, and Revenue
benzinga.com - March 31 at 12:54 AM
markets.businessinsider.com logoPositive Report for ProQR (PRQR) from JMP Securities
markets.businessinsider.com - March 30 at 9:52 AM
MarketBeat logoJMP Securities Upgrades ProQR Therapeutics (NASDAQ:PRQR) to Outperform
americanbankingnews.com - March 30 at 7:46 AM
finanznachrichten.de logoProQR Therapeutics N.V.: ProQR Announces Initial Pipeline Targets and Highlights Axiomer RNA Editing Platform Technology at R&D Event
finanznachrichten.de - March 29 at 2:49 PM
msn.com logoWhy Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
msn.com - March 29 at 2:49 PM
fool.com logoWhy Shares of ProQR Therapeutics Dropped on Wednesday
fool.com - March 29 at 12:42 PM
finance.yahoo.com logoProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event
finance.yahoo.com - March 29 at 9:48 AM
msn.com logoEarnings Outlook For ProQR Therapeutics
msn.com - March 28 at 1:09 PM
MarketBeat logoProQR Therapeutics (NASDAQ:PRQR) Receives Average Recommendation of "Hold" from Brokerages
americanbankingnews.com - March 25 at 3:50 AM
marketbeat.com logoProQR Therapeutics (NASDAQ:PRQR) Receives Consensus Recommendation of "Hold" from Analysts
marketbeat.com - March 20 at 2:15 AM
marketbeat.com logoProQR Therapeutics (NASDAQ:PRQR) Stock Rating Lowered by StockNews.com
marketbeat.com - March 15 at 1:14 AM
Get ProQR Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRQR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PRQR) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -